Drug intelligence / Profile preview

HYOXI-HC

Development stage: Unknown
Lead developer: H & W Labs
Modality: Small Molecules
Administration: Oral

Overview

HYOXI-HC is an oral antioxidant dietary supplement developed and marketed by H & W Labs. Formulated as a soft gelatin capsule, it contains a combination of beta carotene, zinc sulfate, selenium dioxide, manganese, and copper. The supplement is designed to protect cells against oxidative stress, neutralize free radicals, support immune system function, and promote overall cellular and skin health.

Brand names: HYOXI-HC
Other names: HYOXI-HC Antioxidant Soft Gel Capsules

Beyond the preview

Go deeper on HYOXI-HC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HYOXI-HC.